Abstract

Results from several studies have demonstrated the efficacy of intravenous epoprostenol (prostacyclin) for the treatment of pulmonary hypertension. Use of this medication requires a permanent central venous catheter, with its related risks for infection and thrombosis. Aerosolized iloprost, a stable prostaglandin analogue, has been proposed as an alternative to intravenous medication. …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call